CRISPR·유전자 편집 원천기술·치료제 개발 기업
For reference only. Not investment advice. You are solely responsible for your investment decisions.
5/31 · Real-time
No gainers
CRISPR·유전자 편집 원천기술·치료제 개발 기업 Switch between Korean and US stock tabs below to see live prices.
유전자가위·CRISPR 관련주 is a key investment theme in 2026. CRISPR·유전자 편집 원천기술·치료제 개발 기업 PFlow tracks 11 related stocks — 7 Korean and 4 US — with live prices in one view.
There are 11 stocks related to 유전자가위·CRISPR 관련주 — 7 Korean and 4 US stocks. Check live prices and performance in the tabs above.
PFlow's 유전자가위·CRISPR 관련주 page (pflow.app/en/theme/gene-editing) shows Korean and US leading stocks with live price changes. Click any stock to view detailed data.
Korean 유전자가위·CRISPR 관련주 stocks are 7 KOSPI/KOSDAQ-listed companies, while US 유전자가위·CRISPR 관련주 stocks are 4 NASDAQ/NYSE-listed companies. Comparing both helps gauge global demand trends and valuation differences.
※ This page provides price information for companies with business connections to the listed theme. It is not a recommendation to buy or sell any specific stock. Investors are solely responsible for their investment decisions. Please conduct thorough research before investing.